Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Candel Therapeutics Inc CADL

Healthcare Biotechnology
Candel Therapeutics, Inc. is a BLA-ready clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic antitumor immune response to help patients fight cancer. CAN-2409 is the lead product candidate from the adenovirus platform. CAN-3110 is the lead product candidate from the herpes simplex virus (HSV... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CADL)

Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire 18 hours ago

Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors

GlobeNewswire 9 days ago

Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London

GlobeNewswire 10 days ago

Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board

GlobeNewswire October 16, 2025

Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.

GlobeNewswire October 14, 2025

Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer

PR Newswire October 14, 2025

Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine

GlobeNewswire October 14, 2025

Candel Therapeutics to Present at the SITC 2025 Annual Meeting

GlobeNewswire October 3, 2025

Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025

GlobeNewswire September 29, 2025
View More News ››

Opinion & Analysis (NDAQ:CADL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CADL)

Buy buddy buy because it's taking off this morning.

This stock is signalling a big uptrend today
coolfooldumbguy - February 20, 2025

CADL Stock Offering Ouch

CADL Stock Offering Ouch
10QKing - December 12, 2024

MODIFIED VIRUS IMMUNOTHERAPY

What a grest concept in cancer treatment. It seems to work on almost any cancer. They chose the three toughest ones to start.. GBM ...
Tarbaby - May 6, 2024
View more Bullboard ››

Mirasol Resources Ltd.

Mirasol Resources Ltd.

Mirasol Resources Ltd. is a Canada-based mineral exploration company focused on quality copper, gold and silver discoveries ...
View More »